Blood Testing Market Demand Growth 2025 To 2032

Posted 2026-03-10 06:00:50

Market Overview

The Blood Testing Market performs diagnostic procedures that analyze blood samples to detect diseases while evaluating organ function and monitoring treatment effectiveness. Blood tests function as essential diagnostic instruments throughout healthcare facilities to perform screening tests and diagnose diseases and track treatment responses for various medical conditions including infections and cardiovascular diseases and cancer and diabetes and autoimmune disorders. The market provides multiple testing options including complete blood count (CBC), lipid panel, glucose testing, coagulation tests and molecular diagnostics which use PCR and ELISA-based tests. The market achieves operational efficiency and patient convenience through automation in hematology analyzers and point-of-care (POC) testing and digital health platform integration.

Key Players

Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers, BioRad Laboratories Inc, Thermo Fisher Scientific Inc, Quest Diagnostics, Laboratory Corporation of America Holdings LabCorp, Becton Dickinson and Company BD, BioMrieux, Ortho Clinical Diagnostics, Grifols, Sysmex Corporation, Danaher Corporation, QIAGEN, Nipro Corporation, BioTechne Corporation, ARUP Laboratories, Sekisui Diagnostics, DiaSorin, Mindray BioMedical Electronics Co Ltd

Sample link - https://www.trendbridgeinsights.com/industry-report/blood-testing-market

Market segmentation:

Product Type

· Complete Blood Count CBC

· Basic Metabolic Panel BMP

· Lipid Panel

· Liver Panel

· Renal Panel

Test Type

· Glucose Testing

· Cholesterol Testing

· Infectious Disease Testing

· Drug Testing

· Pregnancy Testing

End User

· Hospitals

· Diagnostic Laboratories

· Blood Banks

· Home Healthcare

· Others

Application

· Infectious Diseases

· Oncology

· Diabetes

· Cardiology

· Nephrology

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

North America leads the blood testing market because of advanced healthcare systems, strong diagnostic funding, and high preventive screening rates. Europe follows with robust public health programs and strict EMA regulations that support widespread diagnostic adoption. Asia-Pacific grows fastest as China, India, and Japan expand healthcare access. Latin America and MEA show steady growth driven by modernization efforts despite infrastructure gaps.

Recent development :

In April 2025, Quest Diagnostics launched AD Detect, a novel blood-based immunoassay for detecting Alzheimer’s disease pathology (tau/Aβ ratio) with over 90% sensitivity and specificity—presented at the AAN Annual Meeting.

FAQ:

1 . What is the Forecasted market size & CAGR of the Blood Testing Market ?

The Blood Testing Market achieved USD 95.2 billion in 2024, and it is expected to reach USD 153.7 billion by 2031 at a 7.1% compound annual growth rate (CAGR) throughout the forecast period.

2. Who are the leading manufacturers and suppliers in the Blood Testing Market ?

Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers, BioRad Laboratories Inc, Thermo Fisher Scientific Inc, Quest Diagnostics, Laboratory Corporation of America Holdings LabCorp

3. What are the upcoming trends of Blood Testing Market in the globe?

Rise of Liquid Biopsy Testing: Liquid Biopsy Testing advances through non-invasive tests which utilize circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) to detect cancer early and monitor disease progression.

4. Which is the largest regional market for Blood Testing Market ?

North America holds the leadership position in the global Blood Testing Market, due to its developed healthcare facilities and established diagnostic systems and strong preventive healthcare adoption rates.

About US: